| Literature DB >> 27762625 |
Michele Malagù1, Alessandra Ferri1, Ottavia Mancuso1, Filippo Trevisan1, Marianna Nardozza1, Matteo Bertini1.
Abstract
Implantable cardioverter defibrillator (ICD) is the cornerstone of primary and secondary prevention of sudden cardiac death. In 35 years of technologic improvement and clinical trials, there has been a continuous increase in implantation rate. Purpose of this review is to point out and discuss every aspect related to actual ICD management, investigating implantation procedure and predischarge care, office and remote monitoring follow-up, diagnostic evaluations, management of patients with suspected therapies or malfunctions, heart failure, surgery, radiotherapy and endoscopic procedures. Also, ICD backface such as infections and other complications will be discussed. Finally, we will focus on interesting future perspectives for this setting of patients.Entities:
Keywords: ICD; arrhythmias; device; implantable cardioverter defibrillator; prevention; sudden cardiac death
Mesh:
Year: 2016 PMID: 27762625 DOI: 10.2217/fca-2016-0031
Source DB: PubMed Journal: Future Cardiol ISSN: 1479-6678